Inventor
LI HONGBIN
CN39 patents
⚠️ This page may combine multiple inventors who share the name “LI HONGBIN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
FORMA THERAPEUTICS INC
15 patentsUS10472342B2Nov 12, 2019
Compounds and compositions for inhibition of FASN
FORMA THERAPEUTICS INC4 citations84
US10399951B2Sep 3, 2019
Compounds and compositions for inhibition of FASN
FORMA THERAPEUTICS INC5 citations84
US10870648B2Dec 22, 2020
Inhibiting CREB binding protein (CBP)
FORMA THERAPEUTICS INC8 citations82
US10995078B2May 4, 2021
Compounds and compositions for inhibition of FASN
FORMA THERAPEUTICS INC1 citations73
US10457655B2Oct 29, 2019
Compounds and compositions for inhibition of FASN
FORMA THERAPEUTICS INC3 citations73
US10450286B2Oct 22, 2019
Compounds and compositions for inhibition of FASN
FORMA THERAPEUTICS INC3 citations73
US11254674B2Feb 22, 2022
Inhibiting CREB binding protein (CBP)
FORMA THERAPEUTICS INC2 citations71
US11535618B2Dec 27, 2022
Fused pyrrolines which act as ubiquitin-specific protease 30 (USP30) inhibitors
FORMA THERAPEUTICS INC2 citations70
US10913753B2Feb 9, 2021
Thienopyridine carboxamides as ubiquitin-specific protease inhibitors
FORMA THERAPEUTICS INC2 citations61
US12378242B2Aug 5, 2025
Inhibiting CREB binding protein (CBP)
FORMA THERAPEUTICS INC0 citations60
US11814386B2Nov 14, 2023
Fused pyrrolines which act as ubiquitin-specific protease 30 (USP30) inhibitors
FORMA THERAPEUTICS INC1 citations60
US11787803B2Oct 17, 2023
Tetrahydro-imidazo quinoline compositions as CBP/P300 inhibitors
FORMA THERAPEUTICS INC0 citations60
US11292791B2Apr 5, 2022
Tetrahydro-imidazo quinoline compositions as CBP/P300 inhibitors
FORMA THERAPEUTICS INC1 citations60
US10800750B2Oct 13, 2020
Compounds and compositions for inhibition of FASN
FORMA THERAPEUTICS INC0 citations52
US12351577B2Jul 8, 2025
Inhibiting cyclic AMP-responsive element-binding protein (CREB)
FORMA THERAPEUTICS INC0 citations50
BAOSHAN IRON & STEEL
9 patentsUS9816165B2Nov 14, 2017
Ultrahigh-strength, high-toughness, wear-resistant steel plate and manufacturing method thereof
BAOSHAN IRON & STEEL2 citations69
US9797033B2Oct 24, 2017
High-strength, high-toughness, wear-resistant steel plate and manufacturing method thereof
BAOSHAN IRON & STEEL2 citations69
US10208369B2Feb 19, 2019
High-hardness low-alloy wear-resistant steel sheet and method of manufacturing the same
BAOSHAN IRON & STEEL1 citations55
US9994926B2Jun 12, 2018
High-hardness, high-toughness, wear-resistant steel plate and manufacturing method thereof
BAOSHAN IRON & STEEL0 citations48
US12359272B2Jul 15, 2025
High-strength high-toughness and wear-resistant composite steel plate and manufacturing method therefor
BAOSHAN IRON & STEEL0 citations47
US10851435B2Dec 1, 2020
Dual-hardness clad steel plate and production method thereof
BAOSHAN IRON & STEEL0 citations46
US10865458B2Dec 15, 2020
Armor plate with 2000 MPA-graded tensile strength, and manufacturing method therefor
BAOSHAN IRON & STEEL0 citations41
US10745785B2Aug 18, 2020
High-performance low-alloy wear-resistant steel plate and method of manufacturing the same
BAOSHAN IRON & STEEL0 citations41
US10494706B2Dec 3, 2019
High-toughness low alloy wear-resistant steel sheet and method of manufacturing method thereof the same
BAOSHAN IRON & STEEL0 citations34
VALO EARLY DISCOVERY INC
3 patentsUS11524966B1Dec 13, 2022
Carboxamides as ubiquitin-specific protease inhibitors
VALO EARLY DISCOVERY INC2 citations72
US10889592B2Jan 12, 2021
Thienopyrazine carboxamides as ubiquitin-specific protease inhibitors
VALO EARLY DISCOVERY INC2 citations71
US12162888B2Dec 10, 2024
Carboxamides as ubiquitin-specific protease inhibitors
VALO EARLY DISCOVERY INC0 citations51